leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Spring 2014: Special Edition: Psychedelics and Education
 
Media > Audio and Video Archive

Welcome to our Audio and Video Archive!

See below for a comprehensive and up-to-date archive of audio and visual files related to psychedelic and medical marijuana research.

contract Audio and Video Archive

July 22, 2014

  Valley Veterans Rally To Support Marijuana Researcher

CBS 5 Arizona highlights a press conference hosted by veterans and community leaders who gathered at the University of Arizona on July 22 to demand the reinstatement of Dr. Sue Sisley, the medical marijuana researcher recently fired by the university. The report describes the various efforts to appeal Sisley’s termination, addresses the political environment surrounding Sisley’s termination, and interviews prominent community members. “I am crestfallen and heartbroken that the university would impede this study as if we’re returning to the dark ages,” said former U.S. Attorney Mel McDonald.




July 22, 2014

  Vets Rally Behind Pot Researcher Set To Be Fired By the UofA

FOX 10 Phoenix reports on the July 22 gathering of veterans, activists, and community leaders at the University of Arizona to demonstrate their support for the reinstatement of marijuana researcher Dr. Sue Sisley, the principal investigator for MAPS’ planned study of marijuana for PTSD in veterans who was recently fired by the university. The report summarizes the circumstances surrounding Sisley’s termination, highlights the perspective of veterans in favor of medical marijuana research, and mentions that letters to appeal the decision were delivered to the Arizona State Board of Regents and the University of Arizona. “You are at a university; it should be about advancing science and understanding that to me is the key element of this,” explains U.S. Army veteran Sean Kiernan. “I think it is a black eye to the University of Arizona to be honest with you, and for her to get terminated and fired based on this study to me is un-American.”




July 1, 2014

  Interview with Rick Doblin, Psychedelic Pioneer & Founder of MAPS

Psychedelic Frontier interviews MAPS Executive Director Rick Doblin, Ph.D., about his career of advocating for research into the therapeutic potential of psychedelics and marijuana. Doblin speaks about the process of creating a non-profit psychedelic research organization, reveals how various psychedelic experiences helped shape his perspective of the world, and lists recent successes surrounding the process of turning MDMA-assisted psychotherapy into a prescription treatment option for PTSD. “The FDA has been pretty much an ally, not in favor of medical marijuana or in favor of psychedelic research, but in favor of science over politics,” explains Doblin. “That, combined with the openness at the Department of Defense and the VA, combined with a growing series of pilot studies that have shown MDMA to be really helpful, suggests that maybe if we can scale up and do the work necessary to raise $15-18 million and treat 400 more people, we’ll be able to get MDMA as a prescription medicine in 2021.”




June 4, 2014

  In Praise of Psychedelics: Rick Doblin and the MAPS Project

Reason TV interviews leaders in the field of psychedelic science about the history and future of research into the therapeutic potential of psychedelics to treat a variety of serious medical conditions. MAPS Founder Rick Doblin speaks about the benefits of psychedelic-assisted psychotherapy, shares information about the history of MAPS and the resurgence of psychedelic research, and speaks about his vision for the future of psychedelics. “By the end of 2021, we are hoping that MDMA would be a prescription medicine,” explains Doblin.




April 29, 2014

  Ecstatic States

The Verge debuts their all-new longform report on the benefits of MDMA-assisted psychotherapy for treating posttraumatic stress disorder (PTSD). The report highlights personal testimonials and researchers’ perspectives about healing trauma with MDMA-assisted psychotherapy, notes the positive shift in public perception about the therapeutic potential of psychedelics, and illustrates the need for significant funding into the future of research into MDMA-assisted psychotherapy to treat PTSD. Vietnam veteran Bob Walker shares how MDMA-assisted psychotherapy helped him recover from PTSD, stating, “I did in 3 sessions what I couldn’t do in thirty, forty years.” MDMA-assisted psychotherapy study participant Rachel Hope also revisits the moment when she found out that she overcame treatment-resistant PTSD. “He comes back and sits down and says, ‘Rachel, you don’t have posttraumatic stress disorder any more,’” recalls Hope, on the verge of tears. “‘You don’t have it.’”




April 22, 2014

  Exploring Psychedelic Medicines

Leading researchers in the fast-growing Canadian psychedelic science field speak about the future of research at Exploring Psychedelic Medicines, an event hosted in Vancouver by MAPS Canada in collaboration with the Canadian Drug Policy Coalition on April 22, 2014.




March 18, 2014

  New Studies Show LSD Reduces Anxiety

HuffPost Live interviews MAPS Founder Rick Doblin, PhD, David Nichols, PhD, and John Halpern, MD, about the recently published results from MAPS’ study of LSD-assisted psychotherapy to treat anxiety associated with advanced-stage illness. The experts speak about the variety of conditions that can potentially benefit from psychedelic-assisted therapy and share their perspectives on the past, present, and future of research in this area.




March 8, 2014

  Science Not Fear - Drug Policy and Medical Research: Virginia Wright at TEDx Santa Cruz

TEDx Santa Cruz hosts Virginia Wright of MAPS to speak about the promise of psychedelic research, how MDMA-assisted psychotherapy can help people overcome PTSD, and how drug policy could be dictated by science instead of fear. “We need to use science, compassion, and not fear to understand these drugs so that we can help heal people,” explains Wright.




March 4, 2014

  MDMA for PTSD: How Ecstasy Is Helping People with Post-Traumatic Stress Disorder

Reason.tv gives an investigative report on research into treating PTSD with MDMA-assisted psychotherapy, through original interviews with MAPS Clinical Investigator Michael Mithoefer, M.D., MAPS Founder Rick Doblin, Ph.D., and a veteran who shares his view on how MDMA-assisted psychotherapy can help people suffering from PTSD.




February 12, 2014

  Psychedelic Drugs: Harmful or Therapeutic?

The Stream explores the current status of research into the therapeutic potential of psychedelics. MAPS Founder Rick Doblin shares promising results from completed psychedelic research and Rachel Hope speaks about how being a study participant in MAPS’ study of MDMA-assisted psychotherapy helped her overcome treatment-resistant PTSD.




December 9, 2013

  Treating Trauma: Richard Rockefeller and Larry Brilliant at the Commonwealth Club

Could MDMA effectively treat—maybe even cure—post-traumatic stress disorder (PSTD)? Dr. Richard Rockefeller says yes—or at least a very strong maybe. He says studies involving a small number of people with moderate to severe treatment-resistant PTSD found most subjects were improved after three treatments with medical-quality ecstasy. He’s cautiously optimistic about the prospect of psychedelic medicine, which he believes could heal the trauma in millions from Darfur to the former Yugoslavia. FDA-approved trials of therapy with ecstasy began in 2004, and Dr. Rockefeller believes the U.S. government will eventually approve using the drug for serious medical treatment if research on larger numbers bears out these early findings. What are the possible downsides to this research and what safeguards should be in place to govern it? Is this too good to be true? Join a conversation about the frontiers of brain science and potential for soothing the human condition.

Richard Rockefeller, M.D., Former Board Member, Rockefeller University; Former Chair, U.S. Advisory Board, Doctors Without Borders

In conversation with Larry Brilliant, M.D., MPH, President, Skoll Global Threats Fund; Co-founder, Seva Foundation

Special thanks to The Commonwealth Club of California.




December 9, 2013

  Ask Rick Doblin Anything: How To Experience Psychedelics?

The Dish asks MAPS Founder Rick Doblin the second in a series of reader-submitted questions about psychedelics. Doblin speaks about the unconscious mind as the guide for psychedelic experiences and emphasizes the importance of having someone nearby to provide a sense of safety.

Watch Part 1 of this video series here.




December 6, 2013

  Ask Rick Doblin Anything: The Myths Of Psychedelics

The Dish asks MAPS Founder Rick Doblin a reader-submitted question about the biggest myth surrounding psychedelic drugs. Clarifying a misconception about the validity of psychedelic experiences, he explains: “They are human experiences that we access through psychedelics, rather than psychedelic experiences that are somehow a foreign implant that are not actually real.”

Watch Part 2 of this video series here.




November 11, 2013

  Marijuana Is Helping Our Vets Cope With War

Huffington Post Live interviews MAPS Founder Rick Doblin, Amy Rising, Ricardo Andre Pereyda, and Dr. Raphael Mechoulam about marijuana for treating posttraumatic stress disorder (PTSD) in veterans. Doblin details the current status of research initiatives focused on turning marijuana into a medicine, speaks about the increase in public support for medical marijuana, and explains the differences in treating PTSD symptoms with medical marijuana compared to MDMA-assisted psychotherapy, which aims at more lasting changes.




November 8, 2013

  Treating Post-Traumatic Stress Disorder with Ecstasy

SBS interviews Rachel Hope about how her life changed after participating in MAPS’ clinical trial of MDMA-assisted psychotherapy for treating PTSD. Martin Williams, founder of Psychedelic Research in Science & Medicine (PRISM), talks about his hopes to bring similar research to Australia, stating, “We are only interested in working with pure MDMA, the effects of which in participants are well categorised and the safety profile is well established.” Rachel Hope describes the impact and effectiveness of this treatment, saying, “My life is incredible,” she says. “I was grateful to just get a little relief but I’m cured of PTSD.”




November 1, 2013

  Psychedelic Science: Magic Mushrooms

Reason sheds light on the resurgence of scientific research into psilocybin mushrooms by interviewing psychedelic researchers Robin Carhart-Harris of Imperial College London and Roland Griffiths of Johns Hopkins University at Psychedelic Science 2013. They speak about the effects of psilocybin on the brain, their research results, and what the implications of this research may be.




October 26, 2013

  The Future of Psychedelic Research: What’s Next?

We are now in the midst of a psychedelic research renaissance, with clinical studies under way at top medical schools and research institutes worldwide. How might psychedelics redefine medicine and science, and how can we effectively reintegrate them into contemporary society? What new directions will the future hold? And what are some post-prohibition models for regulation that are already being envisioned and implemented?

Featuring Gabby Agin-Liebes, Jag Davies, Rick Doblin, Albert Garcia, Ingmar Gorman, Joshua Wickerham




October 25, 2013

  Is the Drug War Blocking the Best PTSD Treatments?

This interdisciplinary panel and discussion will focus on how psychedelic-assisted therapy, medical marijuana, and occupational therapy are helping some veterans for whom conventional treatments are not working. What does a federally approved clinical marijuana study look like for PTSD? What does an MDMA-assisted therapy study protocol look like? How does marijuana help de-escalate PTSD triggers? And what is going on in Congress to address this issue at the federal level?

Featuring Shawn Majors, Alexander Neumeister, Marcela Ot’alora, Bill Piper, Steph Sherer, and Sue Sisley




October 25, 2013

  What Can Psychedelics Teach Us About Drug Misuse and Addiction?

Ayahuasca, ibogaine and psilocybin are helping people face death, cope with trauma, and overcome addiction to alcohol, tobacco, opiates and other drugs. What can we learn from the growing body of scientific research? Can these drugs revolutionize addiction treatment? And how can we enhance the benefits and reduce the harms of psychedelic drug use outside of treatment settings?

Featuring Albert Garcia, John Harrison, Stefanie Jones, Philippe Lucas, Linnae Ponté, and Andrew Tatarsky




October 25, 2013

  Communications Strategies:  Psychedelics as the “New Pot”?

Public discourse around both marijuana and psychedelic drugs has shifted rapidly over the last decade, especially the past few years. Is that where the similarities end? In what ways have marijuana and psychedelics each been re-branded? To what extent can we draw lessons from recent marijuana reform victories when it comes to other drugs? And what are the opportunities and pitfalls for changing hearts and minds about marijuana and psychedelic policies moving forward?

Featuring Tom Angell, Brad Burge, Jag Davies, Aaron Houston, Jason Salzman, and Anna Szostek




October 24, 2013

  Research Impurities: What Do Politics Have to Do With Drug Research?

Drug research is highly politicized. The National Institute on Drug Abuse, which funds 85% of addiction research worldwide, has been accused of using its influence to advance its political agenda. How do politics influence what and who gets studied, the measures used to evaluate drug effects, and the conclusions that are drawn? What are the fundamental biases inherent in the current research environment? How do political, financial and institutional constraints create gaps in our knowledge and shape core myths that have become taken-for-granted “truths” about drugs and people who use drugs? And what can researchers do to overcome some of these problems?

Featuring Shaquita Borden, Rick Doblin, Robert Grantfield, Carl Hart, Sheigla Murphy, Lynn Paltrow, and Sue Sisley




September 30, 2013

  Brad Burge of MAPS on Midwest Real

Midwest Real engages Brad Burge of MAPS in a discussion about the path to legitimizing psychedelics, how the media sensationalizes negative stories about drugs, and about how psychedelic harm reduction and clinical research are changing public perceptions around psychedelics.




September 9, 2013

  Veterans Try Alternative Treatments from Yoga to Marijuana

News21 takes an intimate look at the lives of veterans suffering from PTSD who are finding that alternative treatment methods including yoga and medical marijuana are more helpful for them than standard medications. In the report, MAPS-sponsored researcher Dr. Sue Sisley talks about about the growing need and continued resistance to medical marijuana research for veterans. Sisley notes, “Anytime you dare to ask the government to allow you to do a study on the efficacy of marijuana, it’s going to get blocked. Science should never be shackled by politics.”




August 30, 2013

  Push to Trial Use of Ecstasy in Post-Traumatic Stress Disorder Treatment

The Australian Broadcasting Corporation looks into a potential opening for new research in Australia into treating PTSD with MDMA-assisted psychotherapy. The article features anecdotes from Steve McDonald of Psychedelic Research in Science & Medicine (PRISM), Rick Doblin of MAPS, and Tony Macie, a study participant from MAPS’ U.S. research. Macie is interviewed about his experience receiving MDMA-assisted psychotherapy as a treatment for PTSD, remarking “If anything, immediately after I did it, I wished it would be allowed for a lot of veterans with PTSD. I think it could make beyond a huge impact.”




August 16, 2013

  Warrior Poet Project Podcast Special: MAPS Podcast Featuring Founder Rick Doblin

The Warrior Poet Project Podcast invites MAPS Founder Rick Doblin and psychedelic researcher Charles Grob to engage in a discussion about the role of psychedelics in medicine, the increase of interest and scientific studies focusing on ayahuasca, and how cultural acceptance of psychedelics is rising.




July 22, 2013

  Being Bipolar: Ep. 102 – Psychedelic Harm Reduction

The Being Bipolar podcast interviews Brad Burge of MAPS about the Zendo Project psychedelic harm reduction services, touching on the history of harm reduction, why it’s important, and his thoughts on the success of the fundraising campaign for the Zendo Project on Indiegogo .




July 21, 2013

  Rick Doblin - Fighting the Good Fight | London Real

London Real interviews MAPS Founder Rick Doblin about the history of MAPS, the promising results of the latest research into treating PTSD with MDMA-assisted psychotherapy, and the concept of using psychedelics as tools.




June 30, 2013

  Joe Rogan Experience #371 - Rick Doblin

Rick Doblin and Joe Rogan talk about the politics of psychedelic research, human rights, the future of psychedelic therapy, and the importance of awe-inspiring moments on The Joe Rogan Experience podcast.




June 19, 2013

  Psychedelics for Addiction and How to Change the World with Plants

The Not Just Paleo podcast interviews Brad Burge of MAPS about the promising results from psychedelic research, the differences between for-profit medicine companies and MAPS, and more.




June 14, 2013

  The Intellectual Gentlemen’s Club Interviews Brad Burge of MAPS

The Intellectual Gentlemen’s Club interviews Brad Burge of MAPS about innovative medical treatments developed from psychedelic research, the obstacles surrounding medical marijuana research, and MAPS’ mission.




May 26, 2013

  Jim Fadiman on Psychedelics

Renowned author and researcher James Fadiman, Ph.D. joins the To The Best of Our Knowledge radio show for an interview about psychedelics and their potential for enhancing creativity. Fadiman explains, “These substances are no longer seen as terrifying; they’re being seen as very powerful, like your automobile.”




May 14, 2013

  Report From Psychedelic Science 2013 Conference

Brad Burge of MAPS is interviewed on the Burt Cohen Show about the success of Psychedelic Science 2013, describing what happened when almost 2,000 attendees gathered together to learn about psychedelic research from over 100 speakers. Burge explains the process of MDMA-assisted psychotherapy research in detail while also covering other successful psychedelic research currently taking place around the world.




May 14, 2013

  SeekersWay Interview with Brad Burge of MAPS

SeekersWay interviews MAPS Director of Communication Brad Burge in Oakland at Psychedelic Science 2013, focusing on the success of the event, the connection between psychedelics and spirituality, and how new psychedelic research is providing innovative treatment methods for a variety of serious medical conditions.




May 3, 2013

  Dr. Sue Sisley Talks About Medical Marijuana, PTSD and Scientific Freedom

Dr. Sue Sisley tells Medical Marijuana 411 about why she believes medical marijuana can help people suffering from PTSD, and how NIDA and the DEA are preventing clinical research into the healing potential of marijuana.




May 2, 2013

  Psychedelic Experience: Healing, Growth and Discovery

Sofia University hosts a live discussion between psychedelic researcher James Fadiman, Ph.D., and Brad Burge of MAPS about the potential for psychedelics to be used as tools for healing, growth, and discovery.




April 30, 2013

  Interview with Philippe Lucas, MA - Ayahuasca Use in Drug Addiction

The Dr. Future Show interviews Philippe Lucas, MA at Psychedelic Science 2013 about scientific research into ayahuasca, cannabis, and other substances.




April 26, 2013

  The 180 - Psychedelic Medicine

CBC interviews ayahuasca researcher Gerald Thomas about his recently completed Canadian MAPS-sponsored study of ayahuasca. Thomas educates the CBC audience about the benefits of ayahuasca, sharing early reactions from his study.




April 25, 2013

  Drug Truth Network Interviews Brad Burge

Drug Truth Network interviews MAPS Director of Communications Brad Burge in a podcast focusing on Psychedelic Science 2013. Burge underscores the success of the conference while speaking about conference events and the large turnout of researchers and attendees interested in the science surrounding psychedelic substances.




April 23, 2013

  Study Looks at How Ecstasy Can Possibly Treat PTSD

WDTV provides coverage of current research into treating PTSD with MDMA-assisted psychotherapy, educating their audience about how psychedelic therapy can help people overcome medical conditions.




April 19, 2013

  Psychedelic Science Conference Explores Medical and Therapeutic Value of LSD, Ecstasy and Psilocybin

Southern California Public Radio explores Psychedelic Science 2013. Scientists are presenting massive amounts of research results indicating that psychedelics such as LSD, MDMA, psilocybin, ayahuasca, and more can provide benefits to people suffering from serious medical conditions.




March 27, 2013

  Alexander Ward Speaks About Shamanism and Psychedelics

Hosts Jason and Matt Abbott of The Intellectual Gentlemen’s Club Podcast speak with Alexander Ward about ayahuasca, shamanism, MDMA, psilocybin, MAPS, and much more.




February 26, 2013

  A Return Trip: LSD Gets a Second Look

Research Radio at The New School for Social Research analyzes the past half-century of psychedelic research in an expansive segment featuring New School anthropologist Nick Langlitz. The program details studies focusing on the medical potential of psychedelics, the birth of the psychedelic counterculture, and the future of clinical research into substances including MDMA, LSD, and psilocybin.




February 22, 2013

  Decades-Old Club Drug Sees Resurgence

Bay Area television channel KTVU provides insight into the recent rise in popularity of MDMA, citing numerous references in music and other outlets.




February 21, 2013

  UMass Professor Blocked From Growing Marijuana For Medical Research

Boston’s NPR News Station WBUR 90.9 FM interviews Rick Doblin, Ph.D., of MAPS and Professor Lyle Craker about the federal government’s medical marijuana blockade and how it is affecting proposed scientific research.




February 19, 2013

  Easing End-of-Life Anxiety With Psychedelic Drugs

AirTalk, a KPCC Southern California Public Radio program, educates their audience about how research into the benefits of psychedelics is creating new, effective treatment methods for a variety of serious medical conditions. KPCC interviews researchers Anthony P. Bossis, Ph.D. and Charles Grob, M.D. about the resurgence of studying psychedelics.




February 6, 2013

  Shooting Of ‘American Sniper’ Raises Questions About PTSD Treatment

Quil Lawrence of NPR delivers a story about posttraumatic stress disorder (PTSD) for the program All Things Considered, providing a brief spotlight on MDMA-assisted psychotherapy as a PTSD treatment.




February 4, 2013

  Take Ecstasy to Save Your Marriage?

Kevin Pereira and Ana Kasparian host a segment on The Young Turks focusing on the history of MDMA, describing MDMA as “the perfect therapy drug.”




February 4, 2013

  Mt. Pleasant Doctor Using Ecstasy to Treat PTSD in veterans

ABC News Charleston provides coverage of MAPS’ research MDMA-assisted psychotherapy as a treatment for PTSD, featuring interviews with Clinical Investigator Michael Mithoefer, M.D., and Ret. Maj. Ricky Smith, a veteran who participated in the study.




January 14, 2013

  Trips Beyond Addiction

The Living Hero Radio Show showcases Trips Beyond Addiction, a new audio documentary focusing on how scientists are exploring psychedelics in the treatment of addiction, featuring interviews from Brad Burge of MAPS and other knowledgeable guests.




January 14, 2013

  Cannabis Cuts: The Next Generation

Cannabis Cuts interviews Brad Burge, MAPS Director of Communications, about how psychedelic research is helping transforming medicine, inside and out.




January 12, 2013

  TJ Dawe’s New Play “Medicine”

CBC interviews TJ Dawe about his new solo show called “Medicine,” which tells the story of Dawe and his experience joining a retreat led by famed addictions physician Dr. Gabor Maté.




January 11, 2013

  Street Interviews: Treat PTSD with MDMA?!

The Lip TV interviews everyday people about what they think about treating PTSD with MDMA-assisted psychotherapy, revealing outstanding levels of support as well as an emphasis on risk and responsible use.




December 26, 2012

  Treating PTSD with MDMA-Assisted Psychotherapy Motion Graphic

Post-traumatic stress disorder (PTSD) is a devastating illness. Could MDMA-assisted psychotherapy offer hope? Learn more and find out how you can help by watching this motion graphic.




December 17, 2012

  Blisshrooms

Radiolab interviews Dr. Roland Griffiths about his history of researching the effects of psilocybin mushrooms. He reports that over 75% of study participants describe their psilocybin experience as among the top five most significant moments in their lives.




December 17, 2012

  MDMA & PTSD. Empowering Individuals to Heal Themselves

The Michael Ostrolenk Show hosts MAPS Founder Rick Doblin, interviewing him about the history of psychedelic-assisted psychotherapy research and how current research into MDMA-assisted psychotherapy may provide hope for people diagnosed with PTSD




December 5, 2012

  Patient Talks About Ecstasy Treatment for PTSD

Dr. Sanjay Gupta of CNN interviews Rachel Hope about her experience as a participant in our MDMA-assisted psychotherapy research. “I had all this access to my mind and I could control where I was thinking and going and look at things differently.”




November 30, 2012

  Dr. Sanjay Gupta: Ecstasy as PTSD Treatment?

CNN’s Dr. Sanjay Gupta reports on our research on MDMA-assisted psychotherapy as a PTSD treatment, featuring interviews with researchers, participants, and military experts.

Read Part 1, Part 2, & Part 3 of the CNN article accompanying this video.




November 27, 2012

  Scientists to Test Ecstasy for PTSD Vets

NBC San Diego provides coverage of our MDMA-assisted psychotherapy research with a TV news report detailing how the new treatment can help people suffering from PTSD.




November 27, 2012

  Company Says Ecstasy Helps Post Traumatic Stress Disorder

NBC Los Angeles covers MDMA-assisted psychotherapy on live television, educating the greater Los Angeles area with facts surrounding how the treatment can help people overcome PTSD.




November 24, 2012

  Rick Doblin - Researching MDMA

MAPS Founder Rick Doblin speaks about creating a psychedelic research organization, conducting MDMA-assisted psychotherapy research, and much more.




November 21, 2012

  MDMA as a Treatment For PTSD – Being Bipolar: Ep. 53

The Being Bipolar Podcast interviews MAPS Director of Communications Brad Burge about the recent publication of the results of our long-term follow-up study of MDMA-assisted psychotherapy as a treatment for PTSD.

Listen to the podcast.




November 7, 2012

  Phadroid Live at MAPS 25th Anniversary

Filmed live at Cartographie Psychedelica, MAPS’ 25th Anniversary Conference, on December 10, 2011. Special thanks to Android Jones (visuals), Phaedrana Jones (dance), The Human Experience (music), Illa Goldberg (live violin), Charles Shaw (photography), Andrew J. O’Keefe II (editing), and all who joined us in celebrating 25 years of cutting-edge science, education, and art.




October 20, 2012

  Buddhism and Psychedelics: A Community Discussion with Kokyo Henkel and James Fadiman

Rev. Kokyo Henkel and James Fadiman, Ph.D., engage a diverse crowd in Santa Cruz with a discussion about the similarities between psychedelic and Buddhist experiences. Rev. Kokyo Henkel has been practicing Zen Buddhism since 1990 and James Fadiman, Ph.D., author of The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys has been teaching about, working with and doing research on psychedelic and entheogenic experience for decades.

Watch Buddhism and Psychedelics: A Community Discussion with Kokyo Henkel and James Fadiman




September 27, 2012

  Researchers Discuss MDMA Science

Dr. Robin Carhart-Harris and Dr. David Erritzoe of Imperial College detail their research into MDMA using brain-imaging technology and explain why research into MDMA-assisted psychotherapy for treating PTSD and other mental illnesses may be beneficial.




September 18, 2012

  Ecstasy to Treat Post-Traumatic Stress Disorder?

Professor David Nutt discusses clinical research into MDMA, suggesting that the drug can be used in combination with psychotherapy as a treatment for posttraumatic stress disorder.

Listen to the the BBC Radio excerpt here.




July 24, 2012

  Q&A: Psychedelics in 2012 - Charles Grob MD, James Fadiman

Terrence McNally speaks with psychiatrist Charles Grob, M.D., and psychologist James Fadiman, Ph.D. about their views on recent psychedelic research, in addition to discussing the ideas in Fadiman’s new book, Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys (available in the MAPS Store).

Listen to the discussion here.




July 3, 2012

  Video: Dr. Julie Holland — Editor: “Ecstasy: The Complete Guide”

In this outtake from the upcoming documentary From Neurons to Nirvana, Dr. Julie Holland, M.D., speaks about the success of MDMA in a therapy session with a person who previously refused to acknowledge his past.




July 1, 2012

  Science Weekly Podcast: David Nutt Reveals The Truth About Drugs

Professor David Nutt is featured on The Guardian’s Science Weekly podcast, discussing his new book and the potential of drugs to elevate our understanding of the brain. Nutt, author of Drugs – Without Hot Air: Minimizing the Harms of Legal and Illegal Drugs, has recently proposed research into using MDMA for treating PTSD.

Listen to the podcast here.




June 18, 2012

  Veterans Petition State to Use Pot for PTSD

Colorado Public Radio hosts a discussion about a petition from combat veterans living in Colorado who have the goal of making medical marijuana a prescription treatment for people diagnosed with PTSD. The participants were MAPS Executive Director, Rick Doblin, Ph.D., veteran Joe Hatcher, Brian Vicente of Sensible Colorado, Professor Robert Friedman, and Ron Hyman of the Colorado Department of Public Health and Environment.




June 12, 2012

  Ibogaine Trial “Worth the Risk”

MAPS’ observational study of ibogaine-assisted therapy for addiction treatment in New Zealand is the focus of a 10-minute segment on Television New Zealand. Study investigator Geoff Noller, Ph.D., explains how the study could help find better treatments for people suffering from substance abuse, and New Zealand Community Alcohol and Drug Services (CADS) Director Susanna Galea says that the benefits of the research significantly outweigh the risks.

 




June 1, 2012

  San Francisco Veterans Affairs: Treating PTSD with MDMA-Assisted Psychotherapy

On June 1, 2012, MAPS Founder & Executive Director Rick Doblin, Ph.D. and Clinical Investigator Michael Mithoefer, M.D., spoke at the San Francisco Veterans Affairs Medical Center about treating veterans suffering from PTSD with MDMA-assisted psychotherapy.




May 31, 2012

  MDMA-Assisted Psychotherapy: Research, Results, and Potential

On May 31, 2012, MAPS hosted a free lecture and discussion focusing on the research results for treating PTSD with MDMA-assisted psychotherapy.

The lecture was led by MAPS Founder & Executive Director Rick Doblin, Ph.D. and Clinical Investigator Michael Mithoefer, M.D. The event took place at University of California, San Francisco Medical Center.




May 24, 2012

  Rick Doblin at Entheogenesis Australis 2010: Developing Psychedelics Into Prescription Medicines

MAPS Founder and Executive Director Rick Doblin, Ph.D., spoke at Entheogenesis Australis 2010 about psychedelics and their potential as prescription medicines.




May 3, 2012

  CNN: Psychedelic Therapy for Cancer Patients

CNN explores the use of psychedelic-assisted therapy to help cancer sufferers overcome their anxiety about illness.




April 26, 2012

  Video: 2012 Bioethics Forum: Psychedelic Therapy, Death, and Dying

Videos are now available from Final Passages: Research on Near Death and the Experience of Dying, the 11th Annual International Bioethics Forum. The conference took place from April 26-27, 2012.




April 6, 2012

  Video: James Fadiman on Psychedelic Education at MAPS First Friday Art Tour

On Friday, April 6, MAPS hosted an evening of art, music, and conversations about psychedelic science and medicine at our Santa Cruz, California headquarters. Professor James Fadiman, Ph.D., author of the Psychedelic Explorer’s Guide and co-founder of the Institute for Transpersonal Psychology, led an informative yet casual discussion about psychedelic research and creativity studies, and assessed the uses of psychedelics in therapeutic and clinical settings.

 




April 6, 2012

  MAPS First Friday Art Tour - April 6, 2012

On April 6, 2012, MAPS hosted an event for Santa Cruz’s First Friday Art Tour, featuring breathtaking artwork, a psychedelic research discussion, live music, belly dancing, and much more. We displayed the work of six young artists who support our work by offering their art for sale at our events and online store. Visitors enjoyed live music performances by Cello Joe and Homunculus Rex, plus Balinese dance by Annika Johnson and belly dance by San Francisco-based Hasna Hip Flow. Special thanks go to MAPS intern Bryce Montgomery for filming and editing this video.




April 4, 2012

  Ayahuasca: The Persecution of an Ancestral Culture

The International Center for Ethnobotanical Education, Research, and Service (ICEERS) releases a trailer from the first part of a cinematographic project about ayahuasca, a plant used in traditional ancestral ceremonies in the Amazon, and efforts to develop its therapeutic potential in North America and Europe.




March 31, 2012

  MAPS Founder Rick Doblin on Psychedelic vs. Medical Marijuana Research

MAPS Founder Rick Doblin, Ph.D., speaks to the Drug Truth Network about how psychedelic research charges forward while medical marijuana research continues to be blocked by the federal government. The interview was recorded at the 2012 Students for Sensible Drug Policy national conference in Denver, CO.

Listen to the interview online or download it here (mp3).




March 25, 2012

  MAPS Executive Director Rick Doblin Gives Keynote Speech at 2012 SSDP Conference

On March 25, 2012, MAPS Founder and Executive Director Rick Doblin, Ph.D., gave a keynote speech about psychedelics, drug policy, and social change at the 2012 Students for Sensible Drug Policy Conference in Denver, Colorado. He received a standing ovation for his talk, which addressed how the responsible use of psychedelics can help promote positive social change.


March 16, 2012

  How Psychedelics Can Help Heal Addiction

The second episode of the “My Plain Truth” podcast features an interview with Brad Burge about MAPS’ research into the therapeutic uses of psychedelics. The episode focuses on ibogaine, which seems to hold particular promise for those suffering from addiction.




March 9, 2012

  LSD for Alcoholism

Norwegian researcher Teri Krebs explains to BBC World News how a recent reassessment of clinical trial data from decades ago shows that LSD given to alcoholics produced a clear and consistent beneficial effect on alcohol misuse lasting for at least six months after a single dose.




February 28, 2012

  Video: Could MDMA Have Been Designed with Psychotherapy in Mind?

On February 28, 2012, UK psychiatrist Ben Sessa, M.D., gave an outstanding lecture on the topic of “MDMA: Could It Have Been Designed with Psychotherapy in Mind?” The talk was part of an ongoing Ecology, Cosmos, and Consciousness lecture series taking place at the October Gallery in London.


January 16, 2012

  Dr. Julie Holland Interviewed on Women’s Voices Radio

Dr. Julie Holland is a Board-certified psychiatrist specializing in psychopharmacology. Dr. Holland received her medical degree from Temple University School of Medicine where she performed research on auditory hallucinations, extensively interviewing nearly one hundred psychotic patients. As Assistant Professor of Psychiatry at the NYU School of Medicine, Dr. Holland spent her weekends running psychiatric emergency room at Bellevue Hospital for nine years; her book, Weekends at Bellevue: Lessons from the Psychiatric ER comes from that experience. She is considered a worldwide expert on street drugs, and has been quoted in Time, Harper’s, Slate, the Los Angeles Times, and the Wall Street Journal.

Dr. Holland is also the official medical monitor for MAPS’ MDMA-assisted psychotherapy studies, and author of Ecstasy: The Complete Guide and The Pot Book.

Listen to Dr. Holland’s interview on Women’s Voices Radio here (mp3).




January 13, 2012

  British Columbia Medical Official Discusses MDMA-Assisted Psychotherapy

British Columbia’s chief medical health officer, Dr. Perry Kendall, speaks on a province-wide call-in show on CBC Radio One. He starts off by talking about the medical potential of MDMA, its history as an adjunct to psychotherapy and current research on using it for treating PTSD. Listen to the 30-minute show (MP3).




January 9, 2012

  RIck Doblin Interviewed on CKNW Radio Vancouver

MAPS Founder Rick Doblin speaks with CKNW in Vancouver about recent headlines surrounding the dangers of recreational Ecstasy use, the benefits of MDMA-assisted psychotherapy for PTSD, and MAPS’ efforts to conduct medical marijuana research.

Listen to the interview here (mp3).




January 8, 2012

  Drugs, Inc.: Video of Real Underground MDMA-Assisted Psychotherapy Session

“Ecstasy” (which aired Sunday, January 8) showed the social and environmental devastation caused by the criminal black market in Ecstasy pills, and explored what researchers know—and don’t know—about the pure ingredient, MDMA. The episode included a segment describing the possible therapeutic benefits of MDMA-assisted psychotherapy. Watch this video excerpt of a real underground MDMA-assisted psychotherapy session.




January 5, 2012

  Psychedelic Science in the 21st Century

MAPS’ 2010 “Psychedelic Science in the 21st Century” conference brought together international experts to present on psychedelic research and psychedelic psychotherapy topics for the largest conference dedicated solely to psychedelics in the U.S. in 17 years. There were three full days of programming with concurrent tracks exploring clinical and spiritual applications, issues relevant to healthcare professionals, and social and cultural issues surrounding the therapeutic and recreational uses of psychedelics.

The Cinematic Syndicate has now released the following excellent video about the conference. With a successful 25th anniversary conference and celebration right behind us, we’re all looking forward to the next big event. Keep an eye out in 2013!




December 20, 2011

  Psychedelia: Research and Advocacy at MAPS

Psychedelic drugs and marijuana get a bad rap and deserve serious research, says Brad Burge of the Multidisciplinary Association for Psychedelic Studies (MAPS). Join PsychTalk Radio in exploring why these drugs have picked up stigma and what research is revealing about them. Along the way learn about “the most dangerous man in America,” the failure of DARE, and what Steve Jobs thinks about all this.

Visit PsychTalk Radio to hear this 30-minute interview or download it here (32 MB mp3).




December 3, 2011

  Rick Doblin at Entheogenesis Australis: Will Psychedelic Medicine Transform Culture?

MAPS Founder and Executive Director Rick Doblin, Ph.D., shares his views on the potential of psychedelic research to transform human culture at Entheogenesis Australis 2011.




November 5, 2011

  Honor Thy Daughter author Marilyn Howell Addresses International Drug Policy Reform Conference

On November 5, 2011, Honor Thy Daughter author Marilyn Howell was given the honor of speaking at the closing plenary at the 2011 International Drug Policy Reform Conference. Howell was one of a handful of presenters chosen to address the entire conference audience, owing to the dramatic impact their earlier presentations had on attendees.

Ethan Nadelmann, Ph.D., the founder and executive director of the Drug Policy Alliance, explained why Marilyn’s story about how psychedelic therapy helped ease her daughter’s suffering at the end of her life is so important for the drug policy reform community. “We are about trying to reduce the cumulative pain associated both with drugs and the drug war in our society and around the world,” said Nadelmann. “One of the people who spoke beautifully to this issue…was Marilyn Howell.”

As Marilyn wrote to MAPS after the conference (where Honor Thy Daughter sold out): “I’ve always been a bit of an outsider. As a student of multiple mind/body systems, I selectively chose and integrated a variety of useful principles and tools, but I was never drawn to earn certification in a particular discipline or to join an organization of practitioners. Although I facilitated strong communities in the classroom, I was the guide and gatekeeper, not a peer. I never felt as though I belonged to a community. At 69, I’ve finally found my tribe in MAPS.”




November 5, 2011

  DPA 2011: Sessions on Psychedelics in Science, Medicine, and Law

MAPS was a proud co-host of the 2011 International Drug Policy Reform Conference, which took place November 2-5 in Los Angeles, CA. In addition to over a dozen panels and discussions on medical marijuana, an unprecedented number of sessions were held on the science, culture, and politics of psychedelics with leading members of the psychedelic research community.

Full audio recordings are available through the following links:

Psychedelic Healing: Can Psychedelics Reinvent Medicine…and Society?
With Rick Doblin, Jim Fadiman, Julie Holland, Marilyn Howell, Amanda Feilding, and Neal Goldsmith.

Psychedelic Science: Cross-Disciplinary Perspectives
With Brad Burge, Earth and Fire Erowid (invited), Ralph Metzner, Nese Lisa Senol, Kenneth Tupper, and Jag Davies.

Bad Trips: How to Respond to Unwanted or Dangerous Side Effects of Psychedelics, Opiates & Stimulants
With Luciano Colonna, Rick Doblin, John Harrison, and Eliza Wheeler.

Psychedelics, Religion and Cultural Translation
With Neal Goldsmith, Ralph Metzner, Dimitri “Mobengo” Mugianis, Mona Polacca, Kenneth Tupper, and Jill Harris.

 




November 4, 2011

  2011 International Drug Policy Reform Conference Psychedelic Sessions Available Online

The Drug Policy Alliance has graciously made a number of sessions from the exciting and impactful 2011 International Drug Policy Reform conference viewable online. In addition to Honor Thy Daughter author Marilyn Howell’s closing address, you may also be interested in:




October 31, 2011

  Dr. Julie Holland on treating PTSD with MDMA and Cannabis

New York-based Dr Julie Holland talks about her work with post traumatic stress disorder sufferers in this live videolink talk filmed at the Envisioning a Post Prohibition World event organised by Know Drugs and Open Democracy. Dr. Holland is the official medical monitor for MAPS’ clinical studies.

Dr. Holland has spent her adult life investigating drugs.  At the University of Pennsylvania, she majored in the “Biological Basis of Behavior,” a series of courses combining the study of psychology and neural sciences, with a concentration in drugs and the brain, or psychopharmacology. During her college years, she authored an extensive research paper on MDMA. Dr. Holland received her medical degree from Temple University School of Medicine in 1992. At Mount Sinai Medical Center, she completed a residency program in psychiatry, where she was the creator of a research project which treated schizophrenics with a new medication. She is considered an expert on street drugs and intoxication states, and lectures widely on this topic.




October 18, 2011

  Mind Body Health and Politics Radio Show Hosts Psychedelic Medicine Series

“Mind Body Health & Politics” with Dr. Richard Miller is hosting a series on Psychedelic Medicine, featuring personal interviews with scientists and thinkers in psychedelic and medical marijuana research. “Mind Body Health & Politics” airs the first and third Tuesday of the month at 9 AM on National Public Radio affiliate KZYX FM (Mendocino County Public Radio). You can also listen live online at mindbodyhealthpolitics.org.

Past Shows:

  • Psychedelic Medicine I: Ethnobotany with Dennis McKenna
    Broadcasted September 20, 2011 (mp3).
  • Psychedelic Medicine II: The Historic MDMA study
    Dr. Miller and MAPS researchers Michael Mithoefer, M.D., and Ann Mithoefer, B.S.N., discuss their FDA-approved clinical trials of 3,4-methylenedioxymethamphetamine (MDMA) as a therapeutic tool to assist psychotherapy for the treatment of posttraumatic stress disorder (PTSD). Broadcasted October 4, 2011 (mp3).
  • Psychedelic Medicine III: The Psychedelic Explorer’s Guide
    Jim Fadiman, Ph.D. discusses his new book The Psychedelic Explorer’s Guide: Safe, Therapeutic and Sacred Journeys (available in the MAPS Store). Broadcasted October 18th, 2011 (mp3).

More Shows:

  • November 1: Mark Blumenthal , Ph.D., founder and executive director of the American Botanical Council.
  • November 15: Dave Nichols, Ph.D., pharmacologist, medicinal chemist, founding president of the Heffter Research Institute, and one of the world’s leading experts on psychedelics.
  • November 29: Charles Grob, M.D., psychiatrist, psilocybin researcher, and conductor of the first government-approved study of MDMA in humans.

The mission of “Mind Body Health and Politics” is to enhance health, provoke thought, expand consciousness, and encourage mental health.




October 18, 2011

  The Other Day at an Undisclosed Location

On October 18, 2011, Health Canada conducted a follow-up inspection of the pharmacy for our planned Phase 2 Canadian study of MDMA-assisted psychotherapy for PTSD. The pharmacy inspection is required under Canadian regulations to ensure that the facility used to store and label the MDMA to be used in the study is adequately secure, and that the proper accountability procedures are in place. Once we obtain clearance from Health Canada we will be able to import the MDMA for the study into Canada from Switzerland.

Watch this brief video made by Canadian documentary filmmaker Arwen Hunter featuring a personal interview with pharmacist Colin Holyk discussing the challenges of negotiating the strict security requirements required by Health Canada and for a look inside the Vancouver pharmacy where the MDMA will be stored.

 




September 13, 2011

  Rick Doblin, Gabor Maté, and Philippe Lucas at Out of Mind Benefit Event for MAPS Canada

On September 13, 2011, MAPS Founder Rick Doblin, Ph.D., physician and author Gabor Maté, M.D., and MAPS Canada board member Philippe Lucas, M.A., explored the implications of the launch of MAPS Canada at Out of Mind: The Therapeutic Application of Psychedelics to Treat PTSD and Addiction, a lecture series and benefit event in Victoria, BC.

 




August 22, 2011

  Honor Thy Daughter Author Marilyn Howell, Ed.D., Interviewed on Women’s Voices Radio

On August 22, 2011, Honor Thy Daughter author Marilyn Howell, Ed.D., was interviewed on Women’s Voices with Janie Rezner on KZYX radio. Download the podcast of this interview to learn how Dr. Howell decided to explore the possibilities of psychedelic psychotherapy to ease her daughter’s final days.

 




August 22, 2011

  Marilyn Howell Interviewed on “Conversations with Charlie Dyer”

On August 22, 2011, Honor Thy Daughter author Marilyn Howell, Ed.D., was interviewed on KNews 94.3 FM on “Conversations with Charlie Dyer” about her experience using psychedelic-assisted therapy to ease her daughter’s passing. The interview is now available for download.




July 30, 2011

  MAPS Psychedelic Research Presentation at 2011 Women’s Visionary Congress

On July 30, 2011, MAPS staff Amy Emerson (Clinical Program Manager) and Linnae Ponté (Executive & Clinical Research Assistant) gave an interesting and informative presentation about the current state of psychedelic research at the 2011 Women’s Visionary Congress.

Their presentation addressed the prominent role of women in the field of psychedelic therapy research and explored how MAPS’ balanced, respectful approach to its work makes it especially effective as a non-profit pharmaceutical development organization.

The Women’s Visionary Congress (http://visionarycongress.org/) is an annual gathering of visionary women healers, scholars, activists and artists who study consciousness and altered states. The WVC supports the transfer of knowledge among women who apply the insights of their research and spiritual path.





contract MAPS Podcasts

Subscribe to future MAPS podcasts here.

If the above link does not work for you try this alternate one instead.
note: requires iTunes in order to complete subscription process

Psychedelic Science Presenter Podcasts

Podcast 12: Ken Allen interviews conference presenter Thomas Pinkson.

Podcast 11: Ken Allen interviews conference presenter Andreas Hernandez.

Podcast 10: Ken Allen interviews conference presenter Steven Toth.

Podcast 9: Ken Allen interviews conference presenter Kevin Feeney.

Podcast 8: Ken Allen interviews conference presenter Maggie Quinlan.

Podcast 7: Ken Allen interviews conference presenter Kenneth Tupper.

Podcast 6: Ken Allen interviews conference presenter and author James Fadiman.

Podcast 5: Ken Allen interviews conference presenter and WVC founder Annie Oak.

Podcast 4: Ken Allen interviews conference presenter and visionary artist Alex Grey. They discuss his recent car accident and his upcoming workshop at the Psychedelic Science conference.

Podcast 3: Ken Allen interviews conference presenter Diana Slattery, Ph.D.c.

Podcast 2: Ken Allen interviews psychotherapist and curator of conference tracks 2 and 3, Neal Goldsmith, Ph.D.

Podcast 1: Ken Allen interviews Ayahuasca Researcher Rachel Harris, Ph.D.

Psychedelic Spotlight Podcasts

MAPS Director of Communication and Conference Organizer Randolph Hencken, M.A. spoke on Chico's KZFR 90.1 FM's program Shatter Lives about the Psychedelic Science in the 21st Century conference.

December, 2009 Podcast - MAPS' Psychedelic Spotlight, hosted by Ken Allen, featuring a interview with ITP's Alicia Danforth.

November, 2009 Podcast - MAPS' Psychedelic Spotlight, hosted by Ken Allen, featuring a interview with MAPS Staffer Brian Wallace.

August, 2009 Podcast - MAPS' Psychedelic Spotlight, hosted by Ken Allen, featuring a 2 part interview with MAPS Board Member John Gilmore (Part 2).

August, 2009 Podcast - MAPS' Psychedelic Spotlight, hosted by Ken Allen, featuring a 2 part interview with MAPS Board Member John Gilmore (Part 1).

June, 2009 Podcast - MAPS' Psychedelic Spotlight, hosted by Ken Allen, debuted with an interview with MAPS President Rick Doblin Ph.D.

MAPS' Spring 2009 Podcast - Author David Jay Brown talks about the Ecology and Psychedelics special edition of the MAPS Bulletin.

MAPS' 2007 Podcast - Dr. Michael Mithoefer discusses his MDMA-assisted psychotherapy for posttraumatic stress disorder study.

MAPS' February, 2007 Podcast - DEA Administrative Law Judge recommends Prof. Craker get a license to grow marijuana at University Massachusetts Amherst, sponsored by MAPS.

MAPS' 2006 Podcast - Jag Davies, former MAPS Director of Communications, discusses Professor Craker's lawsuit agaist DEA seeking a MAPS-sponsored medical marijuana production facility.

LSD Problem Child and Wonder Drug, International Symposium Podcasts

MAPS' January 2006 Podcasts- Interviews and lectures from the LSD Problem Child and Wonder Drug, International Symposium on the occasion of the 100th Birthday of Albert Hofmann.



contractEducational Video: Psychedelic Crisis

This educational video produced by MAPS is a practical introduction to the principles of psychedelic therapy. This educational video teaches psychedelic drug users how to minimize psychological risks and explore the therapeutic applications of psychedelics. Narrated by Ingrid Pacey, Ph.D., the video demonstrates examples of when and how to help another person make the most out of a difficult experience with psychedelics.

A Practical Introduction to the Principles of Psychedelic Therapy


1) Create a safe space
2) Sitting, not guiding
3) Talk through, don't talk down
4) "Difficult" is not necessarily "bad."

Working with Difficult Psychedelic Experiences was originally produced for the curriculum of a church-based harm reduction drug education program for teenagers, but is intended as a tool for anyone who has ever used psychedelics, for anyone who might in the future, for anyone who knows someone who has ever used psychedelics, or for anyone who knows someone who might in the future. In other words, you!

To download the short video in mpeg4 .MOV (quicktime) format
right click here and select 'save target as'.

To download the short video in flash .flv (flash video) format
right click here and select 'save target as'.

To download the full length director's cut of video in mpeg4 .MOV (quicktime) format right click on each part below and select 'save target as'.

Psychedelic Crisis Video:



contractVideo: 1962 Good Friday Experiment

In 1962, the legendary Good Friday Experiment took place in Marsh Chapel at Boston University and demonstrated that psilocybin can catalyze mystical experiences in people who are religiously inclined and take it within a religious setting. For the first time since the service itself, the stirring Good Friday service by Reverend Howard Thurman (Dr. Martin Luther King Jr.'s mentor) is available for anybody to listen to. Rev. Thurman's sermon and service are powerfully moving on their own, without any chemical enhancement.

The Good Friday Sermon is available in 2 parts: Part 1 (67 MB mp3) and Part 2 (12 MB mp3). Right-click (or command-click) to save file to your computer - please note these are large files and may take some time to download or load in your browser.

In addition MAPS has posted Dr. Walter Pahnke's thesis about the Good Friday Experiment and Rick Doblin's paper on his 25-year follow-up to the original experiment. With the recent  psilocybin/mystical experience research by Roland Griffiths and William Richards at Johns Hopkins, the scientific study of the mystical experience is starting to flourish in the 21st Century.  Eva Pahnke, Walter’s widow, gave the tape of Rev. Thurman to Rick Doblin over 20 years ago.


Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.